Conducting an ePain Assessment: Asking the Right Questions, Using the Best ToolsPremiere Date: Monday, July 27, 2020
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, July 27, 2021
Note: Credit Is No Longer Available
|Steven P. Stanos, DO
Executive Medical Director, Rehabilitation and Performance Medicine
Swedish Pain Services
Swedish Health System
Pain is much more than nociception. It is influenced by a number of psychological and social factors; therefore, it is imperative that physical, functional, and psychosocial assessment tools are used when evaluating pain, whether in person or conducted remotely via Telehealth. These tools include the GAD-7, PHQ-9, pain catastrophizing and opioid risk tools, unimodal pain scales, as well as common pain intensity scales such as the Numeric Rating Scale (NRS), Verbal Descriptor Scale (VDS), and Faces Pain Scale-Revised (FPS-R). It is vital that clinicians are equipped with strategies and best approaches to administering these tools throughout the current COVID-19 pandemic.
Case-based learning is helpful in illustrating not just strategies for managing challenging patients, but also in sharing experiences and insights on maintaining quality care when facing changes in clinical workflow. To help clinicians adapt to virtual appointments, this CME Outfitters BriefCase features expert faculty presenting a case vignette that demonstrates tips for performing psychosocial and physical assessments via a telehealth appointment in order to educate clinicians on appropriate management of pain and the viability of Telehealth for pain evaluation and ongoing management.
At the end of this CE activity, participants should be able to:
- Apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, dentists, PAs, NPs, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
REMS: In order for this activity to count towards your REMS requirements, you must complete the posttest and evaluation. CME Outfitters is responsible for submitting your completion to the FDA for REMS requirements.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABPN MOC Credit:
ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.
Royal College MOC Credit:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
This course meets the Dental Board of California’s requirements for .5 units of continuing education.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
Note to PAs: PAs may claim a maximum of .5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME or a recognized state medical society.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Stanos reports that he is a consultant for Pfizer Inc.; Salix Pharmaceuticals; Sanofi; and SCILEX Pharmaceuticals, Inc.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).